These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport. Nelson AE; Ho KK Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent? Rogol AD Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146 [TBL] [Abstract][Full Text] [Related]
5. IGF-I abuse in sport: current knowledge and future prospects for detection. Guha N; Sönksen PH; Holt RI Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615 [TBL] [Abstract][Full Text] [Related]
6. Potential benefits of recombinant human growth hormone (rhGH) to athletes. Graham MR; Baker JS; Evans P; Hullin D; Thomas NE; Davies B Growth Horm IGF Res; 2009 Aug; 19(4):300-7. PubMed ID: 19539505 [TBL] [Abstract][Full Text] [Related]
7. Detection of GH abuse in sport: Past, present and future. Barroso O; Schamasch P; Rabin O Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501 [TBL] [Abstract][Full Text] [Related]
8. GH & IGF Research issue on doping with growth hormone. Sönksen PH; Holt RI Growth Horm IGF Res; 2009 Aug; 19(4):283-4. PubMed ID: 19535276 [No Abstract] [Full Text] [Related]
9. The history of doping and growth hormone abuse in sport. Holt RI; Erotokritou-Mulligan I; Sönksen PH Growth Horm IGF Res; 2009 Aug; 19(4):320-6. PubMed ID: 19467612 [TBL] [Abstract][Full Text] [Related]
10. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse. Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802 [TBL] [Abstract][Full Text] [Related]
11. The psychology behind doping in sport. Ehrnborg C; Rosén T Growth Horm IGF Res; 2009 Aug; 19(4):285-7. PubMed ID: 19477668 [TBL] [Abstract][Full Text] [Related]
13. The International Olympic Committee (IOC) and GH-2000. Sönksen P Growth Horm IGF Res; 2009 Aug; 19(4):341-5. PubMed ID: 19473864 [TBL] [Abstract][Full Text] [Related]
14. Rogue athletes and recombinant DNA technology: challenges for doping control. Azzazy HM; Mansour MM Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796 [TBL] [Abstract][Full Text] [Related]
15. Overview of the legal framework applicable to the marker method for the detection of human growth hormone. Young RR; Bielak JS; Horvitz SL Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446 [TBL] [Abstract][Full Text] [Related]
16. hGH-abuse in athletes. Strasburger CJ; Wu Z; Bidlingmaier M Ann Endocrinol (Paris); 2007 Sep; 68(4):306-7. PubMed ID: 17651684 [No Abstract] [Full Text] [Related]
17. Commentary on Graham et al.: physical effects of short-term rhGH administration in abstinent steroid dependency. Sonksen PH; Holt RI Horm Res; 2008; 69(6):355-6. PubMed ID: 18504394 [No Abstract] [Full Text] [Related]
18. Technology insight: detecting growth hormone abuse in athletes. Bidlingmaier M; Strasburger CJ Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):769-77. PubMed ID: 17955018 [TBL] [Abstract][Full Text] [Related]